This inventor holds 2 USPTO granted patents. Top assignees: Daiichi Pharmaceutical Co., Ltd., Drug Delivery System Institute, Ltd., Other. Active years: 2002-2005.
Company Filing History:
1 out of 200 
1 out of 12 
1 out of 834,411 Years Active: 2002-2005
Title: Akiko Togo: Innovator in Drug Complexes
Introduction
Akiko Togo is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug complexes that exhibit high antineoplastic activity. With a total of 2 patents, her work focuses on enhancing the selectivity and efficacy of drug compounds.
Latest Patents
Her latest patents include innovative drug complexes characterized by the binding of a drug compound residue, such as antineoplastic agents, to a carboxy(C)alkyldextran polyalcohol. This binding is achieved through a spacer that comprises either an amino acid or peptide-bonded amino acids. These complexes are designed to target tumorous sites effectively, thereby reducing toxicity while maximizing therapeutic effects.
Career Highlights
Throughout her career, Akiko Togo has worked with notable companies, including Daiichi Pharmaceutical Co., Ltd. Her expertise in drug development has positioned her as a key figure in the pharmaceutical industry.
Collaborations
She has collaborated with esteemed colleagues such as Kazuhiro Inoue and Hiroshi Susaki, contributing to advancements in her field.
Conclusion
Akiko Togo's innovative work in drug complexes showcases her dedication to improving cancer treatment options. Her contributions continue to influence the pharmaceutical landscape significantly.